View How working with an agile CRO gets you more from your clinical trial budget

How working with an agile CRO gets you more from your clinical trial budget

The process of taking a pharmaceutical drug through its drug discovery pathway can be challenging, time consuming, and expensive. It’s why more and more leading biotech and pharma companies choose to outsource clinical research work to contract research organisations (CROs) instead.

Read More

View PHARMExcel celebrates 13 successful years!

PHARMExcel celebrates 13 successful years!

This month PHARMExcel reaches yet another milestone as it celebrates 13 years of successful business.

Read More

View New EU Clinical Trial Regulation

New EU Clinical Trial Regulation

The new EU clinical trial regulation (CTR) is set to revolutionise clinical trial processes across Europe impacting all European Member states and organisations wanting to run clinical trials across these regions. How can organisations prepare for the change and set themselves up successfully with a new CTR programme?

Read More

View Yvanne Enever, Founder/CEO reflects on 2021

Yvanne Enever, Founder/CEO reflects on 2021

We are pleased to say that 2021 has seen PHARMExcel busier than ever. From delivering the Worlds’ first Booster Vaccine clinical trial leading to the shaping of UK Government policy, to welcoming new, key staff appointments and undertaking several charity events for Macmillan Cancer Support, Team PHARMExcel showed dedication to the cause. As we complete…

Read More

View PHARMExcel, a U.K. based CRO, is delighted to have been selected as the CRO to support the COVBoost study. Data has contributed to the MHRA approval decisions

PHARMExcel, a U.K. based CRO, is delighted to have been selected as the CRO to support the COVBoost study. Data has contributed to the MHRA approval decisions

Read More

View PHARMExcel to support trial delivery of world-first Covid-19 vaccine booster study.

PHARMExcel to support trial delivery of world-first Covid-19 vaccine booster study.

PHARMExcel is delighted to be announced as the UK Contract Research Organisation (CRO) supporting University Hospital Southampton in the delivery of a world-first Covid-19 vaccine booster study. The Cov-Boost study, backed by £19.3 million of government funding through the Vaccines Taskforce, will be run at University Hospital Southampton, University Hospitals Dorset and the Portsmouth Research…

Read More

View PHARMExcel instrumental in supporting the re-opening of Biotherapy Services DFU trial

PHARMExcel instrumental in supporting the re-opening of Biotherapy Services DFU trial

Biotherapy Services are very pleased to announce our RAPID-1 (Diabetic Foot Ulcer) trial has enrolled and  dosed its first patient following suspension of the trial due to the Covid-19 pandemic restrictions.  This could only have been made possible with the collaborative approach from the PHARMExcel team, who took over the trial management in early 2020….

Read More

View PHARMExcel selected as INmuneBio’s UK CRO to lead on their Phase I clinical trial of INKmune in MDS patients

PHARMExcel selected as INmuneBio’s UK CRO to lead on their Phase I clinical trial of INKmune in MDS patients

PHARMExcel are delighted to have be selected as INmuneBio’s  U.K. CRO to lead on their Phase I clinical trial of INKmune, a novel therapy to prime the patient’s own Natural Killer (NK) cells to attack their cancer, in patients with high-risk Myelodysplastic Syndrome (MDS) (EUDRACT 2019-004820-40). This is a single center, Phase I trial and will…

Read More

View Effective CRO Project Management and Fast Track Study Set-Up for an Investigator Initiated COVID-19 study

Effective CRO Project Management and Fast Track Study Set-Up for an Investigator Initiated COVID-19 study

BACKGROUND PHARMExcel was selected to manage a UK, Phase II, combined Investigational Medicinal Product (IMP)/Medical Device study for COVID-19 patients hospitalised in ICU. We were asked to provide Project Management (PM), Monitoring and Safety oversight for the study, from protocol development to close-out. The study involved two sites and numerous teams responsible for key elements…

Read More

  1. Pages:
  2. 1
  3. 2
  4. 3
  5. 4